New data from Johns Hopkins on outcomes after active surveillance

A new article from the group at Johns Hopkins has now confirmed that rates of prostate cancer-specific mortality and progression to metastatic disease are extremely low at 15 years of follow-up in their 18-year-long active surveillance cohort. … READ MORE …

When should therapeutic intervention take place for men on active surveillance?

The fact of the matter is that, as yet, we don’t have a good answer for this question, and it may be many years before we do. The reasons for this are numerous, but we are beginning to get some of the information we need to clarify the situation. … READ MORE …

The Johns Hopkins active surveillance outcomes data to date

A new article available online in the Journal of Clinical Oncology provides updated data on the 769 men enrolled in the Johns Hopkins active surveillance program since 1995. … READ MORE …